TipRanks
Advertisement
Advertisement
AAVantgarde Bio Strengthens Leadership with Senior Regulatory Hire
PremiumPrivate CompaniesAAVantgarde Bio Strengthens Leadership with Senior Regulatory Hire
18d ago
AAVantgarde Bio Highlights Scientific Role at Japanese Gene and Cell Therapy Meeting
Premium
Private Companies
AAVantgarde Bio Highlights Scientific Role at Japanese Gene and Cell Therapy Meeting
2M ago
AAVantgarde Bio Highlights Clinical Progress In Usher Syndrome Gene Therapy
Premium
Private Companies
AAVantgarde Bio Highlights Clinical Progress In Usher Syndrome Gene Therapy
2M ago
Gene Therapy Focus on Usher Syndrome Type 1B Highlights AAVantgarde Bio’s Rare-Disease Strategy
PremiumPrivate CompaniesGene Therapy Focus on Usher Syndrome Type 1B Highlights AAVantgarde Bio’s Rare-Disease Strategy
3M ago
AAVantgarde Bio Builds Momentum in Retinal Gene Therapy as Early Clinical Data Near
Premium
Private Companies
AAVantgarde Bio Builds Momentum in Retinal Gene Therapy as Early Clinical Data Near
3M ago
AAVantgarde Bio Nears Early Clinical Data as Team Heads to BIO International
Premium
Private Companies
AAVantgarde Bio Nears Early Clinical Data as Team Heads to BIO International
3M ago
AAVantgarde Bio Sponsors Global Retinal Disease Conference
PremiumPrivate CompaniesAAVantgarde Bio Sponsors Global Retinal Disease Conference
3M ago
AAVantgarde Bio Showcases LUCE-1 Usher Syndrome Data at UK Eye Genetics Meeting
Premium
Private Companies
AAVantgarde Bio Showcases LUCE-1 Usher Syndrome Data at UK Eye Genetics Meeting
3M ago
AAVantgarde Bio Highlights Advancing Stargardt Disease Gene Therapy Programs During Awareness Week
Premium
Private Companies
AAVantgarde Bio Highlights Advancing Stargardt Disease Gene Therapy Programs During Awareness Week
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100